Loading next page...
/lp/springer_journal/komplikationen-und-nebenwirkungen-bei-konservativer-therapie-4nUJCH4MLq
- Publisher
- Springer Journals
- Copyright
- Copyright © 2018 by Springer Medizin Verlag GmbH, ein Teil von Springer Nature
- Subject
- Medicine & Public Health; Otorhinolaryngology; Neurosurgery
- ISSN
- 0017-6192
- eISSN
- 1433-0458
- DOI
- 10.1007/s00106-018-0513-6
- Publisher site
- See Article on Publisher Site
Abstract
Leitthema 1 1 1,2 HNO 2018 · 66:419–431 I. Küster ·C.Rudack · A. Beule https://doi.org/10.1007/s00106-018-0513-6 Klinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsklinikum Münster, Münster, Deutschland Online publiziert: 16. Mai 2018 Klinik und Poliklinik für Hals-Nasen-Ohrenkrankheiten, Kopf- und Halschirurgie, Universitätsmedizin © Springer Medizin Verlag GmbH, ein Teil von Greifswald, Greifswald, Deutschland Springer Nature 2018 Komplikationen und Nebenwirkungen bei konservativer Therapie rhinologischer Erkrankungen nahmen. Im vorliegenden Artikel wird in Leitlinien zur rhinologischen Therapie Zusatzmaterial online ein Überblick über die aktuell bekannten empfohlenenMedikamente.AlsAusblick Die Online-Version dieses Beitrags (https:// Nebenwirkungen von häufig eingesetz- möglicher zukünftiger Therapieansätze doi.org/10.1007/s00106-018-0513-6) ten Medikamenten bei rhinologischen wurde die Kategorie Antikörperthera- enthält eine Übersicht der gebräuchlichen Erkrankungen (. Infobox 1)sowie Prä- pie in die Arbeit miteinbezogen. Die Rhinologika mit Nebenwirkungsprofil ventionsmaßnahmen und Behandlungs- wissenschaftliche Literatur wurde durch entsprechend den Angaben der Gelben Liste. Beitrag und Zusatzmaterial stehen Ihnen im möglichkeiten dieser Komplikationen Suche unter www.pubmed.com unter elektronischen Volltextarchiv auf http://www. vermittelt. Angabe der jeweiligen Inhaltsstoffe und springermedizin.de/hno zur Verfügung. Sie den Begriffen „side effects“, „adverse finden das Zusatzmaterial am Beitragsende event“ ausgewertet und aktuelle Daten Rhinologika unter „Supplementary Material“. in die Darstellung integriert. Die medikamentöse Therapie rhinolo- In den ausgewerteten Fachinfor- gischer Erkrankungen ist sehr vielfäl- mationen wurden Häufigkeitsangaben
Journal
HNO – Springer Journals
Published: May 16, 2018
Recommended Articles
Loading...
References
-
Zur Begutachtung: Periorbitales Paraffingranulom nach NasennebenhöhlenoperationWeber, R; Keerl, R; Draf, W; Wienke, A; Kind, M
-
Übersicht: Art und Wirkung geläufiger NasentamponadenBeule, AG; Weber, RK; Kaftan, H; Hosemann, W
-
Lipidpneumonie durch Lipid-haltige Nasensprays und -tropfenGanso, M; Goebel, R; Melhorn, S; Schrenk, D; Schulz, M
-
Tolerability and effects on quality of life of liposomal nasal spray treatment compared to nasal ointment containing dexpanthenol or isotonic NaCl spray in patients with rhinitis siccaHahn, C; Böhm, M; Allekotte, S; Mösges, R
-
The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in childrenChen, JR; Jin, L; Li, XY
-
Rhinosinusitis S2k-Leitlinie. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)- Ständige Kommission Leitlinien
-
Clinical study and literature review of nasal irrigationTomooka, LT; Murphy, C; Davidson, TM
-
Saline irrigation for chronic rhinosinusitis (Review)Chong, LY; Head, K; Hopkins, C; Philpott, C; Glew, S; Scadding, G; Burton, MJ; Schilder, AGM
-
Gelbe Liste Online der Medizinische Medien Informations GmbHJurasovic, M; Bouvier, V
-
Nasal saline irrigation in children: a study of compliance and toleranceJeffe, JS; Bhushan, B; Schroeder, JW
-
Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap waterYoder, JS; Straif-Bourgeois, S; Roy, SL; Moore, TA; Visvesvara, GS; Ratard, RC; Hill, VR; Wilson, JD; Linscott, AJ; Crager, R; Kozak, NA; Sriram, R; Narayanan, J; Mull, B; Kahler, AM; Schneeberger, C; Silva, AJ; Poudel, M; Baumgarten, KL; Xiao, L; Beach, MJ
-
Nasal douches for diseases of the nose and the paranasal sinuses—a comparative in vitro investigationCampos, J; Heppt, W; Weber, R
-
Nasal irrigation: an imprecisely defined medical procedurePrincipi, N; Esposito, S
-
Arzneiverordnungs-Report 2016
-
Funktionen und Funktionsstörungen der respiratorischen Schleimhaut der Nase und der NasennebenhöhlenBeule, AG
-
Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestantsArchontaki, M; Symvoulakis, EK; Hajiioannou, JK; Stamou, AK; Kastrinakis, S; Bizaki, AJ; Kyrmizakis, DE
-
Classification of cilio-inhibiting effects of nasal drugsMerkus, P; Romeijn, SG; Verhoef, JC; Merkus, FW; Schouwenburg, PF
-
Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinionsMarple, B; Peter, R; Benninger, M
-
Use of decongestants during pregnancy and the risk of birth defectsYau, WP; Mitchell, AA; Lin, KJ; Werler, MM; Hernández-Díaz, S
-
Arzneimittelsicherheit in Schwangerschaft und Stillzeit. www.embryotox.de. (letzte Änderung: 30.03.2018)Borisch, C; Padberg, S; Hoeltzenbein, M; Oppermann, M; Fritzsche, J; Hultzsch, S
-
Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: risks and benefitsPoetker, DM
-
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitisScadding, GK; Kariyawasam, HH; Scadding, G; Mirakian, R; Buckley, RJ; Dixon, T; Durham, SR; Farooque, S; Jones, N; Leech, S; Nasser, SM; Powell, R; Roberts, G; Rotiroti, G; Simpson, A; Smith, H; Clark, AT
-
Epistaxis and its relationship to handedness with use of intranasal steroid sprayBenninger, MS
-
Techniques of intranasal steroidBenninger, MS; Hadley, JA; Osguthorpe, JD; Marple, BF; Leopold, DA; Derebery, MJ; Hannley, M
-
Intranasal steroids and the myth of mucosal atrophy: a systematic review of original histological assessmentsVerkerk, MM; Bhatia, D; Rimmer, J; Earls, P; Sacks, R; Harvey, RJ
-
Local and systemic safety of intranasal corticosteroidsSastre, J; Mosges, R
-
Iatrogenic Cushing’s syndrome due to dexamethasone nasal dropsKimmerle, R; Rolla, AR
-
Iatrogenes Cushing-Syndrom und Mutatio tarda durch Dexamethason-haltige NasentropfenFuchs, M; Wetzig, H; Kertscher, F; Täschner, R; Keller, E
-
Case report short-term intranasal steroid useDutta, D; Ks, S; Ghosh, S; Mukhopadhyay, S; Chowdhury, S
-
Iatrogenic Cushing’s syndrome caused by intranasal steroid useDursun, F; Kirmizibekmez, H
-
Intranasal corticosteroids and adrenal suppressionBruni, FM; Luca, G; Venturoli, V; Boner, AL
-
Systemic effects of intranasal steroids: an endocrinologist’s perspectiveAllen, DB
-
Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spraySchenkel, EJ; Skoner, DP; Bronsky, EA; Miller, SD; Pearlman, DS; Rooklin, A; Rosen, JP; Ruff, ME; Vandewalker, ML; Wanderer, A; Damaraju, CV; Nolop, KB; Mesarina-Wicki, B
-
Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitisWilson, AM; Sims, EJ; McFarlane, LC; Lipworth, BJ
-
Lack of bone metabolism side effects after 3 years of nasal topical steroids in children with allergic rhinitisEmin, O; Fatih, M; Emre, D; Nedim, S
-
Lack of ocular side effects after 2 years of topical steroids for allergic rhinitisOzkaya, E; Ozsutcu, M; Mete, F
-
Discontinuing nasal steroids might lower intraocular pressure in glaucomaBui, CM; Chen, H; Shyr, Y; Joos, KM
-
Short-course oral steroids alone for chronic rhinosinusitis (Review)Head, K; Chong, LY; Hopkins, C; Philpott, C; Burton, MJ; Schilder, AG
-
Oral steroids and doxycycline: two different approaches to treat nasal polypsZele, T; Gevaert, P; Holtappels, G; Beule, A; Wormald, PJ; Mayr, S; Hens, G; Hellings, P; Ebbens, FA; Fokkens, W; Cauwenberge, P; Bachert, C
-
Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measuresHissaria, P; Smith, W; Wormald, PJ; Taylor, J; Vadas, M; Gillis, D; Kette, F
-
Clinical efficacy of a short course of systemic steroids in nasal polyposisKirtsreesakul, V; Wongsritrang, K; Ruttanaphol, S
-
Systemic corticosteroids for acute sinusitisVenekamp, RP; Thompson, MJ; Hayward, G; Heneghan, CJ; Mar, CB; Perera, R; Glasziou, PP; Rovers, MM
-
Systemic corticosteroid therapy for acute sinusitisVenekamp, RP; Thompson, MJ; Rovers, MM
-
Oral corticosteroid prescribing habits for rhinosinusitis: the American Rhinologic Society membershipScott, JR; Ernst, HM; Rotenberg, BW; Rudmik, L; Sowerby, LJ
-
Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseasesMion, OG; Mello, JF; Dutra, DL; Andrade, NA; Almeida, WL; Anselmo-Lima, WT; Filho, LL; Carvalho, E; Castro, J; Guimarães, RE; Lessa, MM; Maniglia, SF; Meireles, RC; Nakanishi, M; Pignatari, SS; Roithmann, R; Romano, FR; Santos, RP; Santos, MC; Tamashiro, E
-
Short-course oral steroids as an adjunct therapy for chronic rhinosinusitisHead, K; Chong, LY; Hopkins, C; Philpott, C; Schilder, AG; Burton, MJ
-
An overview of current pharmacotherapy in perennial rhinitisMeltzer, EO
-
Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitisLee, TA; Pickard, AS
-
Nonsedating antihistamines should be preferred over sedating antihistamines in patients who driveHennessy, S; Strom, BL
-
Guideline for acute therapy and management of anaphylaxisRing, J; Beyer, K; Biedermann, T; Bircher, A; Duda, D; Fischer, J; Friedrichs, F; Fuchs, T; Gieler, U; Jakob, T; Klimek, L; Lange, L; Merk, HF; Niggemann, B; Pfaar, O; Przybilla, B; Ruëff, F; Rietschel, E; Schnadt, S; Seifert, R; Sitter, H; Varga, EM; Worm, M; Brockow, K
-
Anticholinergic medication use and dementia: latest evidence and clinical implicationsGray, SL; Hanlon, JT
-
Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across EuropePoluzzi, E; Raschi, E; Godman, B; Koci, A; Moretti, U; Kalaba, M; Wettermark, B; Sturkenboom, M; Ponti, F
-
A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitisBachert, C
-
Allergische Rhinokonjunktivitis: Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI)Bachert, C; Borchard, U; Wedi, B; Klimek, L; Rasp, G; Riechelmann, H; Schultze-Werninghaus, G; Wahn, U; Ring, J
-
Treatment of allergic rhinitisSur, DK; Scandale, S
-
Adverse drug reactions of montelukast in children and adultsHaarman, MG; Hunsel, F; Vries, TW
-
Asthma treatments and mental health visits after a food and drug administration label change for leukotriene inhibitorsLu, CY; Zhang, F; Lakoma, MD; Butler, MG; Fung, V; Larkin, EK; Kharbanda, EO; Vollmer, WM; Lieu, T; Soumerai, SB; Wu, AC
-
Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: a nine-year studyBona, D; Fiorino, I; Taurino, M; Frisenda, F; Minenna, E; Pasculli, C; Kourtis, G; Rucco, AS; Nico, A; Albanesi, M; Giliberti, L; D’Elia, L; Caiaffa, MF; Macchia, L
-
Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up studyDetoraki, A; Capua, L; Varricchi, G; Genovese, A; Marone, G; Spadaro, G
-
Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitisOkubo, K; Ogino, S; Nagakura, T; Ishikawa, T
@Phil_Robichaud
@deepthiw
@JoseServera